Source:http://linkedlifedata.com/resource/pubmed/id/10843531
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-6-20
|
pubmed:abstractText |
Apart from a small number of reports from people who are based in hospitals, data on viral load in HIV-infected people in sub-Saharan Africa, where most infections occur, are lacking. We report serum HIV-1 RNA levels in a population-based cohort in rural Uganda using the nucleic acid sequence-based amplification procedure (NASBA) test kit and describe their relation to CD4 counts and World Health Organization (WHO) clinical staging. The median (interquartile range [IQR]) viral loads were 87,000 copies/ml (37,500-295,000 copies/ml) in 40 prevalent cases infected for >6 years, and 31,000 copies/ml (7800-174,000 copies/ml) in 65 incident cases with seroconversion dates within the previous 6 years. Although we found a correlation between viral load and absolute CD4 count (p < .0001), there was no evidence for an association with CD4 decline (p = .1). Overall, there was a significant trend of increasing viral load with worsening clinical stage from a median viral load of 15,000 for those in WHO stage 1 (asymptomatic) to 150,600 copies/ml for those in stage 4 (AIDS; p < .001). However, the association was seen only in incident cases. Thus, we found that the NASBA test on serum was a useful indicator of disease stage especially in persons known to be infected for <6 years. Such baseline data are important for vaccine research, and if antiretroviral drugs become available to more than a few people in Africa, it will be important that accurate viral load estimations are available at least in a proportion of people to monitor the effectiveness of treatment, and measure the compliance and emerging resistance to these drugs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1525-4135
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
167-73
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10843531-Adult,
pubmed-meshheading:10843531-CD4 Lymphocyte Count,
pubmed-meshheading:10843531-Cohort Studies,
pubmed-meshheading:10843531-Female,
pubmed-meshheading:10843531-HIV Infections,
pubmed-meshheading:10843531-HIV-1,
pubmed-meshheading:10843531-Humans,
pubmed-meshheading:10843531-Male,
pubmed-meshheading:10843531-RNA, Viral,
pubmed-meshheading:10843531-Rural Health,
pubmed-meshheading:10843531-Uganda,
pubmed-meshheading:10843531-Viral Load,
pubmed-meshheading:10843531-World Health Organization
|
pubmed:year |
1999
|
pubmed:articleTitle |
HIV-1 RNA levels in an African population-based cohort and their relation to CD4 lymphocyte counts and World Health Organization clinical staging.
|
pubmed:affiliation |
Medical Research Council Programme on AIDS/Uganda Virus Research Institute, Entebbe. mrc@starcom.co.ug
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|